Yet a pioneer study has demonstrated that peripherally expressed plasma gelsolin can affect amyloid-β dynamics in the CNS in two mouse models of Alzheimer's disease (AD) [41]. The gene discussed is GSN; the disease is early-onset autosomal dominant Alzheimer disease.